ESC 365 - Antisense RNA for treatment of phospholamban-induced cardiomyopathies.

ESC Premium Access

Antisense RNA for treatment of phospholamban-induced cardiomyopathies.

Session: The RNA Frontier: Close to Therapeutic Applications?

Topic: Basic Science

Speaker: Professor P. Doevendans (Utrecht, NL)

Event: ESC Congress 2020

Congress Presentation

Add to my library

About the speaker

Professor Pieter Doevendans

University Medical Center Utrecht, Utrecht (Netherlands (The))

2 presentations

0 follower

3 more presentations in this session

Targeting non-coding RNA for treatment of heart failure.

Speaker: Professor T. Thum (Hannover, DE)

Targeting long non-coding RNAs in cardiovascular disease.

Speaker: Professor A. Baker (Edinburgh, GB)

Strategies to solve the problem of RNA delivery in cardiovascular disease.

Speaker: Associate Professor D. Catalucci (Milan, IT)

Access the full session

The RNA Frontier: Close to Therapeutic Applications?

Speakers: Professor P. Doevendans, Professor T. Thum, Professor A. Baker, Associate Professor D. Catalucci

About the event

ESC Congress 2020

29 August - 1 September 2020

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources